My pleasure. As @Red bar has since pointed out, the numbers for pneumonia might superficially seem underwhelming, for the others they are fantastic. Overall, really quite astounding for a first go at a more rigorous study attempting to differentially diagnose a bunch of resp illnesses including a couple of difficult ones in Asthma and Pneumonia. Also the numbers for pneumonia in any study conducted by RAP, now and in the future, are always going to be subject to factors such as the ability of the medical fraternity to define, classify and then diagnose with high certainty using the best methods/ tech available. Given the state of play right now, it isnt without its pitfalls - to understate the issue
RAP Price at posting:
31.3¢ Sentiment: Buy Disclosure: Held